Study presents a revolutionary tool to process a very large number of samples in parallel, allowing wide coverage of the monitored sites in a reduced time and at a lower cost
The technology, called SiMSen-Seq, could aid in detecting the recurrence of cancers, catching possible disease relapses faster than current methods and improving patient outcomes
Most vaccines targeting tumor-associated antigens have had limited success so far in producing therapeutic effects against most cancers due to poor immunogenicity